Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Vesikari

Showing results (101-110 of 211) with videos related to

Pageof 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2010
Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adultsSharon Frey, Timo Vesikari, Agnieszka Szymczakiewicz-Multanowska, et al.
The Pediatric Infectious Disease Journal|February 8, 2006
Neonatal administration of rhesus rotavirus tetravalent vaccineTimo Vesikari, Aino Karvonen, Bruce D Forrest, et al.
The Pediatric Infectious Disease Journal|November 30, 2012
A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled studyTimo Vesikari, Aino Forstén, Maria Guiseppina Desole, et al.
Immunology|November 3, 2011
A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particlesKirsi Tamminen, Leena Huhti, Tiia Koho, et al.
The Pediatric Infectious Disease Journal|November 9, 2018
Implementing Universal Varicella Vaccination in Europe: The Path ForwardVana Spoulou, Sophie Alain, Giovanni Gabutti, et al.
The Pediatric Infectious Disease Journal|June 30, 2009
Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvantTimo Vesikari, Michele Pellegrini, Aino Karvonen, et al.
Vaccine|December 13, 2016
Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infantsTimo Vesikari, Ray Borrow, Xavier Da Costa, et al.
Human Vaccines & Immunotherapeutics|October 4, 2012
Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersTimo Vesikari, Aino Forstén, Dominique Boutriau, et al.
The Pediatric Infectious Disease Journal|April 11, 2015
European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014Timo Vesikari, Pierre Van Damme, Carlo Giaquinto, et al.
The Pediatric Infectious Disease Journal|January 7, 2006
Rotavirus types in Europe and their significance for vaccinationUlrich Desselberger, Judith Wolleswinkel-van den Bosch, Jacek Mrukowicz, et al.
Pageof 22

Showing results (101-110 of 211) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2010
Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adultsSharon Frey, Timo Vesikari, Agnieszka Szymczakiewicz-Multanowska, et al.
The Pediatric Infectious Disease Journal|February 8, 2006
Neonatal administration of rhesus rotavirus tetravalent vaccineTimo Vesikari, Aino Karvonen, Bruce D Forrest, et al.
The Pediatric Infectious Disease Journal|November 30, 2012
A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled studyTimo Vesikari, Aino Forstén, Maria Guiseppina Desole, et al.
Immunology|November 3, 2011
A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particlesKirsi Tamminen, Leena Huhti, Tiia Koho, et al.
The Pediatric Infectious Disease Journal|November 9, 2018
Implementing Universal Varicella Vaccination in Europe: The Path ForwardVana Spoulou, Sophie Alain, Giovanni Gabutti, et al.
The Pediatric Infectious Disease Journal|June 30, 2009
Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvantTimo Vesikari, Michele Pellegrini, Aino Karvonen, et al.
Vaccine|December 13, 2016
Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infantsTimo Vesikari, Ray Borrow, Xavier Da Costa, et al.
Human Vaccines & Immunotherapeutics|October 4, 2012
Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersTimo Vesikari, Aino Forstén, Dominique Boutriau, et al.
The Pediatric Infectious Disease Journal|April 11, 2015
European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014Timo Vesikari, Pierre Van Damme, Carlo Giaquinto, et al.
The Pediatric Infectious Disease Journal|January 7, 2006
Rotavirus types in Europe and their significance for vaccinationUlrich Desselberger, Judith Wolleswinkel-van den Bosch, Jacek Mrukowicz, et al.
Pageof 22